MALTODEXTRINIERTER TRAUBENTRESTEREXTRAKT

European patent · EP4509117 · In force

Register entry

Publication number
EP4509117
Application number
EP24213632
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Mar 26, 2021
Published
Feb 19, 2025
Granted
Jul 22, 2026
Protection ends at the latest
Mar 25, 2041
Next annual fee due
Mar 31, 2027
IPC classes
A61K 36/87 (2006.01)
A61K 31/05 (2006.01)
A61K 31/07 (2006.01)
A61K 31/192 (2006.01)
A61K 31/352 (2006.01)
A61K 31/353 (2006.01)
A61K 31/525 (2006.01)
A61K 31/713 (2006.01)
A61K 33/30 (2006.01)
A23L 33/105 (2016.01)
A61K 9/48 (2006.01)
Priority
IT 202000006493 27.03.2020
Divided from
EP21165097
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 22, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 22.07.2026

Parties

Holder

NGN Healthcare - New Generation Nutraceuticals S.r.l.

Via Nazionale, 207 Torrette, 83013 Mercogliano, IT

Inventor

NOVELLINO, Ettore

83100 Avellino, IT

TENORE, Gian Carlo

80128 Napoli, IT

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.